San Martin Javier
CHIEF MEDICAL OFFICER
San Martin Javier has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including LONA, ATHA, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, San Martin Javier is listed as CHIEF MEDICAL OFFICER at LeonaBio, Inc. Inside the rolling window, San Martin Javier reported no open-market purchases and 2 open-market sales totaling $21K in LONA and ATHA. The largest disclosed transaction in the window is a sale of 1,644 ATHA shares on Jan 2, 2026, worth $11K.
Companies traded
Other insiders at LONA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has San Martin Javier made?
San Martin Javier has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including LONA, ATHA since 2026.
Which companies does San Martin Javier trade?
San Martin Javier has filed SEC Form 4 disclosures for 2 companies, including LONA, ATHA.
When was San Martin Javier's most recent SEC Form 4 filing?
San Martin Javier's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is San Martin Javier's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, San Martin Javier is listed as CHIEF MEDICAL OFFICER.
What is San Martin Javier's total buy and sell value in the current window?
Inside the rolling retention window, San Martin Javier bought $0 and sold $21K based on SEC Form 4 filings.
What was San Martin Javier's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,644 ATHA shares on 2026-01-02, worth $11K, per SEC Form 4 filings.